Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

By afschroeder • January 7, 2026

Amaeshi L, Laufer L, Fedorov K, Sisto A, Levitz D, Mathew R, Wright K, Cooper D, Goldfinger M, Mantzaris I, Sica RA, Gritsman K, Konopleva M, Gupta R, Kornblum N, Zhang C, Kim M, Verma A, Rapkin B, Shastri A, Shah N. Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study. JMIR Cancer. 2026 Jan 6;12:e68101. doi: 10.2196/68101. PMID: 41494164.

Tags: Adherence, African American, Cancer, cancer care, cellular therapy, financial literacy, Financial toxicity, General Internal Medicine, Hematologic malignancies, Hispanic, longitudinal study, medical care, Publications, Quality of Life, questionnaire, Resident, socioeconomically, survival, survival rates, toxicity

Ambient AI Scribes in Clinical Practice: A Randomized Trial

Lukac PJ, Turner W, Vangala S, Chin AT, Khalili J, Shih YT, Sarkisian C, Cheng EM, Mafi JN. Ambient AI Scribes in Clinical Practice: A[...]

North American and European practices for opioid-sparing and opioid-free anaesthesia: a cross-sectional survey

Gricourt Y, Boulos NM, Daoulas Y, Grogan T, Alexander B, Mezzarobba M, Cuvillon P, Pogatzki-Zahn EM, Beloeil H, Cannesson M, Forget P, Joosten A. North[...]

Primary Care Providers’ Perspectives on Barriers and Facilitators to Human Papillomavirus (HPV) Vaccination among Young Adults: A Qualitative Study

Vázquez-Otero C, Owens HN, Arevalo M, Cui J, Chavez MN, Maconi ML, Geiss C, Turner K, Vadaparampil ST, Barrios-Monroy V, Pena A, Whiting J, Christy[...]